Dr. Vokes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1400 Holcombe Blvd
Houston, TX 77030Phone+1 877-632-6789
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2016 - 2019- Brigham and Women's HospitalResidency, Internal Medicine, 2013 - 2016
Harvard Medical SchoolClass of 2013
Certifications & Licensure
FL State Medical License 2021 - Present
GA State Medical License 2022 - 2026
TX State Medical License 2020 - 2026
AZ State Medical License 2022 - 2025
LA State Medical License 2022 - 2025
MS State Medical License 2022 - 2025
OK State Medical License 2022 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma.Giuseppe Tarantino, Cora A Ricker, Annette Wang, William Ge, Tyler J Aprati
Science Advances. 2024-11-29 - 1 citationsCTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, Yu Qian, Xin Sun
Nature. 2024-11-01 - Stratified analysis identifies HIF-2as a therapeutic target for highly immune-infiltrated melanomas.Amy Y Huang, Kelly P Burke, Ryan Porter, Lynn Meiger, Peter Fatouros
Biorxiv. 2024-10-30
Journal Articles
- Genomic Correlates of Response to Immune Checkpoint Blockade in Microsatellite-Stable Solid TumorsJeffrey A Engelman, David A Barbie, Nicole G Chau, Glenn J Hanna, Natalie I Vokes, Sabina Signoretti, Pasi A Janne, Robert I Haddad, Lynette M Sholl, Rizwan Haq, Peter..., Nature
Lectures
- Distinct immunogenomic properties of melanomas with stable disease as best response to immune checkpoint blockade (ICB).2019 ASCO Annual Meeting - 6/1/2019
- Genomic correlates of response to immune checkpoint blockade in microsatellite stable solid tumors.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Press Mentions
Integrative Molecular Characterization of Sarcomatoid and Rhabdoid Renal Cell CarcinomaFebruary 5th, 2021- Integrated Molecular Drivers Coordinate Biological and Clinical States in MelanomaNovember 23rd, 2020
Damon Runyon Announces Recipients of Physician-Scientist Training AwardMay 15th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
